前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：202202234224311300 整理番号：22A0623459

RNF144Aは,GMFG発現を下方制御するためのプロテアソーム分解のためにYY1を標的とすることで乳癌において腫瘍抑制機能を発揮する【JST・京大機械翻訳】

RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression

著者 (20件)：

Zhang Yin-Ling

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Zhang Yin-Ling

(Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China)

,

Cao Jin-Ling

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Zhang Ye

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Liao Li

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Liao Li

(Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China)

,

Deng Ling

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Deng Ling

(Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China)

,

Yang Shao-Ying

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Yang Shao-Ying

(Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China)

,

Hu Shu-Yuan

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Hu Shu-Yuan

(Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China)

,

Ning Yan

(Department of Pathology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China)

,

Zhang Fang-Lin

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Zhang Fang-Lin

(Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China)

,

Li Da-Qiang

(Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism of Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China)

,

Li Da-Qiang

(Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China)

,

Li Da-Qiang

(Department of Breast Surgery, Shanghai Medical College, Fudan University, Shanghai, China)

,

Li Da-Qiang

(Shanghai Key Laboratory of Breast Cancer, Shanghai Medical College, Fudan University, Shanghai, China)

,

Li Da-Qiang

(Shanghai Key Laboratory of Radiation Oncology, Shanghai Medical College, Fudan University, Shanghai, China)

資料名：

Medical Oncology (Medical Oncology)

巻： 39 号： 4 ページ： 48 発行年： 2022年
JST資料番号： W4722A ISSN： 1559-131X 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：ドイツ (DEU) 言語：英語 (EN)

JDreamⅢ複写サービスとは

JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

TOP

BOTTOM